Sfoglia per Autore
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma.
2018 Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobili; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor.
2018 Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E, Ardizzoni A, Massari F
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?
2019 Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F.
Molecular mechanisms related to hormone inhibition resistance in prostate cancer
2019 Mollica V.; Di Nunno V.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Santoni M.; Scarpelli M.; Montironi R.; Massari F.
Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials
2019 Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D.
Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis
2019 Nunno V.D.; Mollica V.; Gatto L.; Santoni M.; Cosmai L.; Porta C.; Massari F.
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice
2019 Massari F.; Nunno V.D.; Mollica V.; Montironi R.; Cheng L.; Cimadamore A.; Blanca A.; Lopez-Beltran A.
Pembrolizumab plus axitinib: A new treatment option for patients with metastatic renal cell carcinoma
2019 Mollica V.; Di Nunno V.; Massari F.
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes
2019 Di Nunno, Vincenzo; Mollica, Veronica; Santoni, Matteo; Gatto, Lidia; Schiavina, Riccardo; Fiorentino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes.
2019 Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F
A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss.
2019 Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Caliò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F
Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End
2019 Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Mollica V.; Porta C.
The human microbiota and prostate cancer: Friend or foe?
2019 Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G.
Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma
2019 Di Nunno, Vincenzo; Massari, Francesco; Mollica, Veronica; Cimadamore, Alessia; Santoni, Matteo; Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo
Toward a genome-based treatment landscape for renal cell carcinoma
2019 Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Caserta C.; Morelli F.; Zafarana E.; Carrozza F.; Mosca A.; Mollica V.; Iacovelli R.; Sabbatini R.; Porta C.; Bracarda S.
Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution
2019 Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Cimadamore A.; Cheng L.; Lopez-Beltran A.; Montironi R.; Pisconti S.; Battelli N.; Massari F.
N-Myc a key gene promoting a worst prostate cancer progression
2019 Di Nunno V.; Mollica V.; Massari F.
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor
2019 Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Battelli N.; Montironi R.; Massari F.
Third-and later-line treatment in advanced or metastatic gastric cancer: A systematic review and meta-analysis
2020 Rizzo A.; Mollica V.; Ricci A.D.; Maggio I.; Massucci M.; Rojas Limpe F.L.; Fabio F.D.; Ardizzoni A.
Oncology clinical trials in the time of COVID-19: How a pandemic can revolutionize patients' care
2020 Massari F.; Mollica V.; Salvagni S.; Tognetto M.; Ardizzoni A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. | Vincenzo Di Nunno; Veronica Mollica; Beniamino Corcioni; Michelangelo Fiorentino; Elisabetta Nobi...li; Riccardo Schiavina; Rita Golfieri; Eugenio Brunocilla; Andrea Ardizzoni; Francesco Massari | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. | Mollica V, Di Nunno V, Corcioni B, Fiorentino M, Nobili E, Schiavina R, Golfieri R, Brunocilla E,... Ardizzoni A, Massari F | 2018-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients? | Di Nunno, V.; Mollica, V.; Gatto, L.; Santoni, M.; Sorgentoni, G.; Battelli, N.; Massari, F. | 2019-01-01 | ANNALS OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | - |
| Molecular mechanisms related to hormone inhibition resistance in prostate cancer | Mollica V.; Di Nunno V.; Cimadamore A.; Lopez-Beltran A.; Cheng L.; Santoni M.; Scarpelli M.; Mon...tironi R.; Massari F. | 2019-01-01 | CELLS | - | 1.01 Articolo in rivista | Cells 2019.pdf |
| Adjuvant Tyrosine Kinase Inhibitors in Treatment of Renal Cell Carcinoma: A Meta-Analysis of Available Clinical Trials | Massari F.; Di Nunno V.; Mollica V.; Graham J.; Gatto L.; Heng D. | 2019-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| Prognostic impact of neutrophil-to-lymphocyte ratio in renal cell carcinoma: A systematic review and meta-analysis | Nunno V.D.; Mollica V.; Gatto L.; Santoni M.; Cosmai L.; Porta C.; Massari F. | 2019-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice | Massari F.; Nunno V.D.; Mollica V.; Montironi R.; Cheng L.; Cimadamore A.; Blanca A.; Lopez-Beltr...an A. | 2019-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Pembrolizumab plus axitinib: A new treatment option for patients with metastatic renal cell carcinoma | Mollica V.; Di Nunno V.; Massari F. | 2019-01-01 | CHINESE CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes | Di Nunno, Vincenzo; Mollica, Veronica; Santoni, Matteo; Gatto, Lidia; Schiavina, Riccardo; Fioren...tino, Michelangelo; Brunocilla, Eugenio; Ardizzoni, Andrea; Massari, Francesco | 2019-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes. | Di Nunno V, Mollica V, Santoni M, Gatto L, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, ...Massari F | 2019-01-01 | CLINICAL GENITOURINARY CANCER | - | 1.01 Articolo in rivista | - |
| A Meta-Analysis Evaluating Clinical Outcomes of Patients with Renal Cell Carcinoma Harboring Chromosome 9P Loss. | Di Nunno V, Mollica V, Brunelli M, Gatto L, Schiavina R, Fiorentino M, Santoni M, Montironi R, Ca...liò A, Eccher A, Milella M, Martignoni G, Brunocilla E, Massari F | 2019-01-01 | MOLECULAR DIAGNOSIS & THERAPY | - | 1.01 Articolo in rivista | - |
| Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End | Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Mollica V.; Porta C. | 2019-01-01 | EUROPEAN UROLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| The human microbiota and prostate cancer: Friend or foe? | Massari F.; Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Bel...tran A.; Cheng L.; Battelli N.; Montironi R.; Brandi G. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-00459.pdf |
| Another one in the chamber: cabozantinib for patients with metastatic non clear cell renal cell carcinoma | Di Nunno, Vincenzo; Massari, Francesco; Mollica, Veronica; Cimadamore, Alessia; Santoni, Matteo; ...Cheng, Liang; Lopez-Beltran, Antonio; Scarpelli, Marina; Montironi, Rodolfo | 2019-01-01 | ANNALS OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | ATM Editorial [Di Nunno CABO] 2019.pdf |
| Toward a genome-based treatment landscape for renal cell carcinoma | Massari F.; Di Nunno V.; Santoni M.; Gatto L.; Caserta C.; Morelli F.; Zafarana E.; Carrozza F.; ...Mosca A.; Mollica V.; Iacovelli R.; Sabbatini R.; Porta C.; Bracarda S. | 2019-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Novel Therapeutic Approaches and Targets Currently Under Evaluation for Renal Cell Carcinoma: Waiting for the Revolution | Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Cimadamore A.; Cheng L.; Lopez-Beltran A.; Montiro...ni R.; Pisconti S.; Battelli N.; Massari F. | 2019-01-01 | CLINICAL DRUG INVESTIGATION | - | 1.01 Articolo in rivista | - |
| N-Myc a key gene promoting a worst prostate cancer progression | Di Nunno V.; Mollica V.; Massari F. | 2019-01-01 | TRANSLATIONAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor | Mollica V.; Di Nunno V.; Gatto L.; Santoni M.; Scarpelli M.; Cimadamore A.; Lopez-Beltran A.; Che...ng L.; Battelli N.; Montironi R.; Massari F. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-11-00830.pdf |
| Third-and later-line treatment in advanced or metastatic gastric cancer: A systematic review and meta-analysis | Rizzo A.; Mollica V.; Ricci A.D.; Maggio I.; Massucci M.; Rojas Limpe F.L.; Fabio F.D.; Ardizzoni A. | 2020-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Oncology clinical trials in the time of COVID-19: How a pandemic can revolutionize patients' care | Massari F.; Mollica V.; Salvagni S.; Tognetto M.; Ardizzoni A. | 2020-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | fon-2020-0364.pdf |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile